Profile picture

Doctor Kazuma Oyama

Tohoku University, Sendai (Japan)
Follow
Logo ESC

Contributor content

Prediction of 10-year risk for recurrent atherosclerotic cardiovascular events in a secondary prevention population: Insights from CHART-2 and Suita studies in the Japanese population
Presentation
Prediction of 10-year risk for recurrent atherosclerotic cardiovascular events in a secondary prevention population: Insights from CHART-2 and Suita studies in the Japanese population
Read more
Acute arterial events across all vascular territories in the FOURIER trial
Presentation
Acute arterial events across all vascular territories in the FOURIER trial
Read more
Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial
Presentation
Influence of cardiovascular drugs on the efficacy and safety of dapagliflozin in patients with type 2 diabetes mellitus in the DECLARE-TIMI 58 trial
Read more
Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48
Presentation
Serial measurement of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in ENGAGE AF-TIMI 48
Read more
Evidence for enhanced inflammation of coronary adventitia and perivascular adipose tissue in patients with vasospastic angina -A multi-modality imaging study-
Presentation
Evidence for enhanced inflammation of coronary adventitia and perivascular adipose tissue in patients with vasospastic angina -A multi-modality imaging study-
Read more
Evidence for involvement of inflammatory changes of perivascular adipose tissue in the pathogenesis of DES-induced hyperconstricting responses in pigs in vivo -Impact of 18F-FDG PET imaging-
Presentation
Evidence for involvement of inflammatory changes of perivascular adipose tissue in the pathogenesis of DES-induced hyperconstricting responses in pigs in vivo -Impact of 18F-FDG PET imaging-
Read more

ESC 365 is supported by

novartis Explore sponsored resources